Self-infusion of prophylaxis: evaluating the quality of its performance and time needed
| Authors | J. Lock, M.H. Cnossen, M. Beijlevelt-van der Zande, Marieke J Schuurmans, M. Peters, L.H. Schrijvers, K. Fischer |
|---|---|
| Published in | Haemophilia |
| Publication date | 2016 |
| Type | Article |
Summary
Prophylactic replacement therapy is the cornerstone of treatment in severe haemophilia. Regular infusions with clotting factor concentrate have been proven effective to prevent bleeding, subsequent (joint) damage, and positively affect the impact of haemophilia on daily life [1]. Patients or parents of younger patients learn to infuse clotting factor concentrate in a peripheral vein (i.v.) or a central venous access device (CVAD) [2].
| Language | Engels |
|---|---|
| Published in | Haemophilia |
| Year and volume | 22 3 |
| Page range | e214-e217 |
Neem contact met ons op
- Telefoon 088 481 81 81
- Email info@hu.nl
-
Stuur ons direct een bericht of voeg +97010241111 toe aan de contactlijst van je telefoon en stel je vraag via WhatsApp.
- Bereikbaar op ma t/m vrij 09.30 - 16.30 uur.